V. K. Emruli

Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma

S. Ek, R. Olsson, V. K. Emruli, 2016, BMC Cancer.

Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma

S. Ek, R. Olsson, V. K. Emruli, 2016, BMC Cancer.

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia

G. Juliusson, M. Jerkeman, S. Ek, 2018, npj Precision Oncology.

Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

K. Grønbæk, M. Jerkeman, S. Ek, 2018, BMC Cancer.

Identification of a serum biomarker signature associated with metastatic prostate cancer

F. Hamdy, D. Neal, J. Donovan, 2021, Proteomics. Clinical applications.